Ponoi Management 13F annual report
Ponoi Management is an investment fund managing more than $77 million ran by James Evangelista. There are currently 4 companies in Mr. Evangelista’s portfolio. The largest investments include RAPT Therapeutics and Ngm Biopharmaceuticals Inc, together worth $55 million.
$77 million Assets Under Management (AUM)
As of 9th May 2022, Ponoi Management’s top holding is 1,599,417 shares of RAPT Therapeutics currently worth over $35.2 million and making up 45.7% of the portfolio value.
Relative to the number of outstanding shares of RAPT Therapeutics, Ponoi Management owns less than approximately 0.1% of the company.
In addition, the fund holds 1,298,908 shares of Ngm Biopharmaceuticals Inc worth $19.8 million, whose value fell 40.3% in the past six months.
The third-largest holding is Revolution Medicines Inc worth $17.5 million and the next is Nurix Therapeutics worth $4.58 million, with 327,122 shares owned.
Currently, Ponoi Management's portfolio is worth at least $77 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Ponoi Management
The Ponoi Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, James Evangelista serves as the Chief Financial Officer at Ponoi Management.
Recent trades
James Evangelista disclosed a decreased stake in Nurix Therapeutics by 0.4%.
This leaves the value of the investment at $4.58 million and 327,122 shares.
One of the smallest hedge funds
The two most similar investment funds to Ponoi Management are Wealthspring Capital and Newfound Research. They manage $76.9 million and $76.9 million respectively.
James Evangelista investment strategy
Ponoi Management’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $751 million.
The complete list of Ponoi Management trades based on 13F SEC filings
These positions were updated on May 16th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| RAPT Therapeutics, Inc. |
No change
1,599,417
|
$35,171,000 | 45.65% |
| Ngm Biopharmaceuticals Inc |
No change
1,298,908
|
$19,808,000 | 25.71% |
| Revolution Medicines Inc |
No change
685,011
|
$17,475,000 | 22.68% |
| Nurix Therapeutics, Inc. |
41.75%
327,122
|
$4,583,000 | 5.95% |
| No transactions found | |||
| Showing first 500 out of 4 holdings | |||
Hedge funds similar to Ponoi Management
- Corbett Road Capital Management
- Skyline Asset Management L.P.
- Peoples Bank Ntl Association
- Alphadyne Asset Management L.P.
- Caz Investments L.P.
- Premise Capital
- Kpcb Xv Associates
- Wealthspring Capital
- Newfound Research
- Carronade Capital Management, L.P.
- Accel London Iii Associates L.P.
- Pw Partners Capital Management
- Yarger Wealth Strategies
- Oslo Asset Management As